权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Decoding microbial-Aryl Hydrocarbon Receptor interactions at the skin barrier interface

解码皮肤屏障界面处的微生物-芳基烃受体相互作用

基本信息

批准号：
10689803
负责人：
AAYUSHI UBEROI
金额：
$ 9.06万
依托单位：
UNIVERSITY OF PENNSYLVANIA
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10689803
关键词：
Acne Adhesions Advisory Committees Air Pollutants Allergens Aryl Hydrocarbon Receptor Atopic Dermatitis Attenuated Bioinformatics Communities Complex Coupled Data Set Dehydration Disease Ecology Ecosystem Environment Environmental Exposure Epidermis Epithelium Flowers Functional disorder Genetic Transcription Germ-Free Gnotobiotic Goals Home Homeostasis Human Immune In Vitro Infection Inflammation Knock-out Ligand Binding Ligands Mass Spectrum Analysis Mediating Mentors Metagenomics Modeling Multiomic Data Mus Names Pathway interactions Patients Pennsylvania Permeability Phase Precision therapeutics Premature aging syndrome Probiotics Psoriasis Receptor Signaling Regulation Research Resources Role Rosacea Signal Transduction Skin Skin repair System Systems Biology Testing Therapeutic Tight Junctions Training Tryptophan Tryptophan Metabolism Pathway UV induced Ultraviolet Rays Universities Xenobiotics aryl hydrocarbon receptor ligand career cell type commensal microbes design efficacy testing epithelial repair high throughput screening host microbiome host microbiota improved inhibitor member metabolomics metagenomic sequencing microbial microbial community microbiome microbiota mouse model multiple omics novel therapeutics pathogen pollutant prevent repaired response sensor skills skin barrier skin disorder skin microbiome targeted treatment therapeutic evaluation tool transcription factor transcriptome sequencing transcriptomics

项目摘要

PROJECT SUMMARY An effective epidermal permeability barrier (EPB) protects the skin from dehydration, inflammation, premature aging, environmental exposure, and infection. Epidermal barrier dysfunction is an important feature of atopic dermatitis, as well as numerous skin diseases including psoriasis, acne, and rosacea. A fundamental and holistic understanding of mechanisms regulating homeostatic barrier function is essential to effectively prevent and manage barrier abnormalities. The EPB function resides in the skin epidermis, which is home to diverse microbial communities. The microbiome is recognized as a functional unit of the skin barrier. The skin ecosystem is continuously challenged by the external exposome that includes ultraviolet radiation (UVR), air pollutants and allergens. Critical for the barrier defense and homeostasis are xenobiotic sensors that recognize external signals and help identify beneficial (e.g., commensal microbes) from harmful (e.g., pollutants, pathogens) xenobiotics to regulate barrier defenses. Recently, I have demonstrated that commensal microbes regulate epidermal differentiation and barrier permeability of the skin by activating xenobiotic sensor, the aryl hydrocarbon receptor (AHR). However, the mechanisms by which commensal microbes regulate EPB through AHR under homeostasis, and in presence of environmental insults such as UVR are unexplored. The central hypothesis of this proposal is that tuning of epithelial responses by modulating AHR-commensal interactions can alter barrier permeability. This project utilizes ‘multi-omics’ approaches by integrating transcriptomics, metagenomics, and metabolomics to understand host-microbiota interactions in skin barrier repair. In Aim 1, I will identify microbial signals from a synthetic commensal community that can activate AHR. These studies will lead to identification of microbial ligands that can be used to target AHR in barrier diseases. In Aim 2, I will test contributions of commensal microbiome in protecting against UV-induced barrier damage and use multiomics approaches to characterize microbiome-host-UV interactome in the context of AHR signaling. These studies will provide a framework to generate therapies that leverage understanding of environmental-host-microbiome interactions. During the K99 phase, I will be trained in metabolomics to identify microbial metabolites. I will receive advanced training in bioinformatics and systems biology approaches that focus on integrating multiple omics datasets. The outstanding training environment at the University of Pennsylvania coupled with the excellent advisory committee I have assembled, will greatly facilitate my research during the mentored phase as well as launch my career with the skills necessary for understanding the role of the microbiome-host- environment interactome in regulating skin barrier repair.

项目总结有效的表皮渗透性屏障(EPB)保护皮肤免受脱水、发炎、早熟衰老、环境暴露和感染。特应性皮肤屏障功能障碍是特应性疾病的重要特征皮炎，以及包括牛皮癣、粉刺和酒渣鼻在内的多种皮肤病。一个基本的和全面了解动态平衡屏障功能的调节机制是有效预防并管理障碍异常。EPB功能驻留在皮肤表皮，它是各种微生物群落。微生物群被认为是皮肤屏障的一个功能单位。皮肤生态系统不断受到外部曝光体的挑战，包括紫外线(UVR)、空气污染物和过敏原。对于屏障防御和动态平衡至关重要的是识别外部信号并帮助识别有益(例如，共生微生物)和有害(例如，污染物，病原体)调节屏障防御的外源生物。最近，我证明了共生微生物通过激活异物感受器芳香来调节皮肤的表皮分化和屏障通透性烃受体(AHR)。然而，共生微生物调控EPB的机制是通过 AHR在动态平衡下，以及在存在诸如UVR等环境侮辱的情况下，尚未被探索。中环这一建议的假设是通过调节AHR-共生相互作用来调节上皮反应可以改变屏障的渗透性。该项目通过整合转录组学来利用“多组学”方法，元基因组学和代谢组学，以了解皮肤屏障修复中宿主-微生物区系的相互作用。在目标1中，我将识别来自可激活AHR的合成共生群落的微生物信号。这些研究将导致鉴定可用于针对屏障疾病中的AHR的微生物配体。在《目标2》中，我将测试共生微生物组在抗紫外线屏障损伤中的作用及应用多组学在AHR信号背景下表征微生物组-宿主-UV相互作用组的方法。这些研究将提供一个框架来产生利用对环境-宿主-微生物组的理解的治疗方法互动。在K99阶段，我将接受代谢组学方面的培训，以识别微生物代谢物。这就做接受生物信息学和系统生物学方法方面的高级培训，重点是将组学数据集。宾夕法尼亚大学出色的培训环境，加上我组建的优秀的咨询委员会，将极大地促进我在指导阶段的研究。以及开始我的职业生涯所需的技能，以了解微生物组宿主的角色- 环境在调节皮肤屏障修复中的作用。